The management of chronic conditions often requires patients to take daily medication for an
extended duration. However, the need for daily dosing can lead to nonadherence to the …

Midazolam is a commonly used benzodiazepine in palliative care and is considered one of
the four essential drugs needed for the promotion of quality care in dying patients. Acting on …

Background Among some patients with human immunodeficiency virus type 1 (HIV-1)
infection who have undergone multiple antiretroviral therapies and have limited options for …

Efavirenz (Sustiva®) is a first-generation non-nucleoside reverse transcriptase inhibitor
(NNRTI) used to treat human immunodeficiency virus (HIV) type 1 infection or to prevent the …

Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the
concomitant use of multiple drugs. DDI may occur in patients under treatment with …

Despite substantial progress in confronting the global HIV-1 epidemic since its inception in
the 1980s, better approaches for both treatment and prevention will be necessary to end the …

Acquired Immunodeficiency Syndrome (AIDS) is a chronic disease characterized by multiple
life-threatening illnesses caused by a retro-virus, Human Immunodeficiency Virus (HIV). HIV …

Introduction: Drugs used in HIV treatment; all protease inhibitors, some non-nucleoside
reverse transcriptase inhibitors, and pharmacoenhancers ritonavir and cobicistat can inhibit …

The combined antiretroviral therapy (cART) can efficiently suppress HIV replication, but the
cessation of cART usually results in viral rebound, mostly due to the presence of viral …

Prevention, assessment, and identification of drug–drug interactions (DDIs) represent a
challenge for healthcare professionals, especially in nosocomial settings. This narrative …